Hematopoietic growth factors and glucocorticoids synergize to mimic the effects of IL-1 on granulocyte differentiation and IL-1 receptor induction on bone marrow cells in vivo.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Experimental Hematology

• Publication date

  1993-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7678814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo interleukin-1 (IL-1) administration indirectly promotes type II IL-1 receptor expression on hematopoietic bone marrow cells: novel mechanism for the hematopoietic effects of IL-1.

  1991cited by this paper
• Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells.

  1991cited by this paper
• Increased expression of the interleukin 1 receptor on blood neutrophils of humans with the sepsis syndrome.

  1991cited by this paper
• Interleukin-1 and interleukin-1 antagonism.

  1991cited by this paper
• IL-1 modulation of cytokine receptors on bone marrow cells. In vitro and in vivo studies.

  1991cited by this paper
• Granulocyte colony-stimulating factor modulation of cytokine receptors on murine bone marrow cells. In vivo and in vitro studies.

  1991cited by this paper
• Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.

  1990cited by this paper
• Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action

  1990cited by this paper
• In vivo modulation with anti-interleukin-1 (IL-1) receptor (p80) antibody 35F5 of the response to IL-1. The relationship of radioprotection, colony-stimulating factor, and IL-6.

  1990cited by this paper
• Role of interleukin-1 in hematopoiesis

  1989cited by this paper
• Protective effects of IL-1 on human hematopoietic progenitor cells treated in vitro with 4-hydroperoxycyclophosphamide.

  1989cited by this paper
• Flow cytometric analysis of the effect of interleukin-1 administration on bone marrow populations in mice.

  1989cited by this paper
• In vivo hematopoietic effects of recombinant interleukin-1 alpha in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin.

  1989cited by this paper
• Regulation of hemopoiesis in myelosuppressed mice by human recombinant IL-1 alpha.

  1989cited by this paper
• Interleukin 1 stimulates its own receptor expression on human fibroblasts through the endogenous production of prostaglandin(s).

  1988cited by this paper
• Induction of high-affinity interleukin 1 receptor on human peripheral blood lymphocytes by glucocorticoid hormones

  1988cited by this paper
• Interleukin-1 enhances murine granulopoiesis in vivo.

  1988cited by this paper
• Modulation of interleukin-1 receptor expression and interleukin-1 response in fibroblasts by platelet-derived growth factor.

  1988cited by this paper
• Chemotactic activity of recombinant human granulocyte colony-stimulating factor.

  1988cited by this paper
• Comparison of in vivo effects of human recombinant IL 1 and human recombinant IL 6 in mice.

  1988cited by this paper
• Effects of hematopoietin-1 and interleukin 1 activities on early hematopoietic cells of the bone marrow.

  1988cited by this paper
• The in vivo effects of interleukin 1. I. Bone marrow cells are induced to cycle after administration of interleukin 1.

  1987cited by this paper
• Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.

  1987cited by this paper
• Induction of colony stimulating factor in vivo by recombinant interleukin 1 alpha and recombinant tumor necrosis factor alpha 1.

  1987cited by this paper
• Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).

  1987cited by this paper
• Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1.

  1987cited by this paper
• Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones.

  1986cited by this paper
• Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2.

  1986cited by this paper
• Interleukin-1 (22-K factor) induces release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes.

  1986cited by this paper
• Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells.

  1986cited by this paper
• There is more than one interleukin 1.

  1986cited by this paper
• Interleukin 1 is a radioprotector.

  1986cited by this paper
• Binding of 125I‐labeled granulocyte colony‐stimulating factor to normal murine hemopoietic cells

  1985cited by this paper
• Evidence for specific receptors for interleukin 3 on lymphokine-dependent cell lines established from long-term bone marrow cultures.

  1984cited by this paper
• Possible Involvement of Leukocytic Endogenous Mediator in Granulopoiesis

  1977cited by this paper

• Critical Neurotransmitters in the Neuroimmune Network

  2020cites this paper
• Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types

  2019cites this paper
• KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study

  2019cites this paper
• Understanding the Cellular Origin of the Mononuclear Phagocyte System Sheds Light on the Myeloid Postulate of Immune Paralysis in Sepsis

  2018cites this paper
• Impact d’une infection par le virus grippal de type A sur la myélopoïèse

  2018cites this paper
• Etude de la modulation des cellules myeloïdes murines au cours de l'endotoxémie

  2017cites this paper
• Fight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis

  2015cites this paper
• phase I/II clinical trial Interleukin-1 alpha administered after autologous transplantation: a

  2011cites this paper
• Modifying radiation damage.

  2010cites this paper
• Three Promoters Regulate Tissue- and Cell Type-specific Expression of Murine Interleukin-1 Receptor Type I*

  2009cites this paper
• Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process

  2004cites this paper
• Impaired hepatic granuloma formation in mice deficient in C–C chemokine receptor 2

  2003cites this paper
• Cytokine modulation of liver annexin 1 expression during experimental endotoxemia.

  2001cites this paper
• Effects of G-CSF and high-dose methylprednisolone on peripheral stem cells, serum IL-3 levels and hematological parameters in acute lymphoblastic leukemia patients with neutropenia: a pilot study.

  2000cites this paper
• Essential Role for the P55 Tumor Necrosis Factor Receptor in Regulating Hematopoiesis at a Stem Cell Level

  1999cites this paper
• Pretreatment with Glucocorticoids Enhances T-Cell Effector Function: Possible Implication for Immune Rebound Accompanying Glucocorticoid Withdrawal

  1999cites this paper
• Intermittent-low dose G-CSF treatment in a patient with chronic neutropenia.

  1998cites this paper
• Multiplicity of glucocorticoid action in inhibiting allograft rejection.

  1998cites this paper
• Dexamethasone and interleukin-1 potently synergize to stimulate the production of granulocyte colony-stimulating factor in differentiated THP-1 cells.

  1997cites this paper
• Effects of dexamethasone treatment on IL‐1 receptor mRNA levels in vivo

  1997cites this paper
• Benefit of simultaneous rhG-CSF and methylprednisolone 'pulse' therapy for methotrexate-induced bone marrow failure in rheumatoid arthritis.

  1997cites this paper
• Corticosteroids alter hematopoiesis in vitro by enhancing human monocyte secretion of granulocyte colony-stimulating factor.

  1997cites this paper
• Recombinant cytokines and hematopoietic growth factors in allogeneic and autologous bone marrow transplantation.

  1997cites this paper
• Regulation of cytokine and cytokine receptor expression by glucocorticoids

  1996cites this paper
• Interleukin-1 alpha administered after autologous transplantation: a phase I/II clinical trial.

  1994cites this paper
• Inhibition of bone marrow-derived natural suppressor activity by glucocorticoids and its reversal by IFN-gamma or IL-2.

  1994cites this paper
• Bacterial endotoxin regulation of cytokine receptors on murine bone marrow cells: in vivo and in vitro study.

  1994cites this paper
• Synergy of IL-1 and stem cell factor in radioprotection of mice is associated with IL-1 up-regulation of mRNA and protein expression for c-kit on bone marrow cells.

  1994cites this paper